trial · primary record
Buloxibutid
Idiopathic Pulmonary Fibrosis (IPF)
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 378 |
| Primary completion | 2027-06 |
| Primary endpoint | To evaluate the efficacy of buloxibutid compared to placebo in participants with IPF as assessed by FVC |
| Registry ID | NCT06588686 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:23.106Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06588686
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.